19 June 2013
Keywords: vernalis, shares, up, serono, returns, anti-inflammatory, drugs
Article | 27 October 2008
Shares in Vernalis rose 10% to 2.93 pence after a portfolio of compounds it licensed to Swiss firm Serono reverted to the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 October 2008
© 2013 thepharmaletter.com